Assetmark, Inc
- SEC CIK
- 0001344551
- Latest filing
- Jul 30, 2026
SVA holding history
Sinovac Biotech Ltd in every 13F filed by Assetmark, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SVA overviewAll 13F holders of SVAFull Q2 2026 holdings
- Shares (Q2 2026)
- 63
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 63 | $0 | 0.0% | +37+142.3% | Added | Holders |
| Q1 2026 | 26 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q4 2025 | 26 | $0 | 0.0% | +2+8.3% | Added | Holders |
| Q3 2025 | 24 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2025 | 24 | $0 | 0.0% | +24 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −21−100.0% | Sold out | Holders |
| Q3 2024 | 21 | $0 | 0.0% | +5+31.3% | Added | Holders |
| Q2 2024 | 16 | $0 | 0.0% | +3+23.1% | Added | Holders |
| Q1 2024 | 13 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q4 2023 | 13 | $0 | 0.0% | −1−7.1% | Reduced | Holders |
| Q3 2023 | 14 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2023 | 14 | $0 | 0.0% | +14 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −14−100.0% | Sold out | Holders |
| Q4 2022 | 14 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q3 2022 | 14 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2022 | 14 | $0 | 0.0% | +4+40.0% | Added | Holders |
| Q1 2022 | 10 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q4 2021 | 10 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q3 2021 | 10 | $0 | 0.0% | +10 | New | Holders |